The Remarkable Advancement of ICSI Over IVF

The introduction of Intracytoplasmic Sperm Injection (ICSI) marked a significant milestone in assisted reproductive technology, offering new hope and solutions for couples grappling with infertility, particularly stemming from male factors. This specialized procedure has distinct differences and advantages over traditional In Vitro Fertilization (IVF) that make it uniquely effective. Monash Biotech, a leader in the field and India’s only manufacturer of ICSI micropipettes, is at the forefront of supporting IVF centers across the nation with cutting-edge tools needed for this advanced technique.

In 1992, Gianpiero Palermo and Andre Van Steirteghem achieved the first successful pregnancy using intracytoplasmic sperm injection (ICSI) in Brussels, Belgium.

How Intracytoplasmic Sperm Injection (ICSI) Works ?

ICSI involves the direct injection of a single sperm into an egg using a specially designed micropipette. This process bypasses many of the natural barriers to fertilization, making it particularly useful for cases where sperm quantity, quality, or motility is a concern. After injection, the fertilized egg is monitored for growth and development before being transferred to the uterus.

The Use of ICSI Injection

The primary use of ICSI is to overcome male fertility issues such as low sperm count, poor sperm motility, or abnormal morphology. It is also used in cases where sperm must be retrieved surgically from the testicles or epididymis, and in situations where previous IVF attempts have not resulted in fertilization.

How is ICSI Different from IVF?

While IVF involves mixing multiple sperm with an egg in a lab dish and allowing fertilization to occur naturally, ICSI takes a more direct approach by injecting a single sperm into the egg. This method significantly reduces the chances of fertilization failures, especially in situations where sperm quality or quantity is compromised.

Is ICSI Better than IVF?

Whether ICSI is better than IVF depends on specific infertility issues. For male infertility, ICSI offers a higher chance of successful fertilization compared to traditional IVF. However, for couples where male infertility is not a factor, IVF remains a robust option.

FAQs for Embryologists

Q: What configurations are available for Monash Biotech Injection Micropipettes with a spike?

A: The micropipettes with a spike are available in 30° and 35° angled configurations with a bevel length of 11 μm and an inner diameter (I.D.) of 05 μm

Q: What are the available configurations for Blastomere Biopsy Micropipettes?

A: Monash Biotech offers three categories of Blastomere Biopsy Micropipettes, each with various angles and designs: Straight, flat & 15° to 45° angled micropipettes (Catalogue No. MBB-F-S) Flat & 15° to 45° angled micropipettes (Catalogue No. MBB-F-M) Bevelled 15° to 45° angled micropipettes (Catalogue No. MBB-B) Each category has specific models with different angles and identical inner diameters (I.D.) of 30μm or 35μm.

Q: Where I can find the brochure of the product ?

A: You can find the product brochure in Resource Page (www.monashbiotech.com/resources).

Q: How are Blastomere Biopsy Micropipettes supplied?

A: These micropipettes are supplied in boxes containing 10 individually packed and sterile units. This packaging format facilitates convenient handling and storage in the laboratory.

ICSI Key Findings

Recent studies and ongoing research continue to refine ICSI techniques, improving success rates and outcomes. Innovations in micropipette technology and better understanding of sperm selection are pivotal areas of focus.

ICSI Micropipette’s Role in the ICSI or IVF Market

ICSI micropipettes, such as those manufactured by Monash Biotech, are essential for the precise manipulation required in ICSI. Their design and quality directly influence the ease and success of the procedure.

IVF Market Overview and Growth in India

The IVF market in India is expected to grow significantly in the coming years due to rising awareness of fertility issues, increasing availability of treatments, and advancements in technology. As families continue to seek effective solutions, the demand for specialized procedures like ICSI is anticipated to rise.

Monash Biotech — India’s Only ICSI Micropipette Manufacturer !

As India’s premier ICSI micropipette manufacturer, Monash Biotech is dedicated to empowering IVF centers across India with the highest quality products. Our commitment to enhancing assisted reproductive technology ensures that every couple has the best possible chance to fulfill their dream of parenthood. With our expertise, we remain at the forefront of the IVF industry, contributing to its growth and the success of fertility treatments nationwide.